AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+1.29%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$8.89B
AUM Growth
-$1.49B
(-14%)
Cap. Flow
-$1.59B
Cap. Flow
% of AUM
-17.93%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124
Top Buys
| 1 |
Energy Transfer Partners
ET
|
+$33.8M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$30.5M |
| 3 |
Newmont
NEM
|
+$30M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
| 5 |
Conagra Brands
CAG
|
+$24.9M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$430M |
| 2 |
JPMorgan Chase
JPM
|
+$162M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$132M |
| 4 |
Pfizer
PFE
|
+$111M |
| 5 |
Yum! Brands
YUM
|
+$105M |
Sector Composition
| 1 | Energy | 59.33% |
| 2 | Technology | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRE
351
DELISTED
Duke Realty Corp.
DRE
| $1.05M | 0.01% |
+15,982
| New | +$1.05M |
|
352
Johnson & Johnson
JNJ
$426B
| $1.03M | 0.01% |
6,023
-175,282
| -97% | -$30M |
|
353
Praxis Precision Medicines
PRAX
$843M
| $1.02M | 0.01% |
3,460
-210
| -6% | -$62.1K |
|
354
Stoke Therapeutics
STOK
$1.21B
| $1.02M | 0.01% |
42,571
-2,463
| -5% | -$59.1K |
|
355
Vanda Pharmaceuticals
VNDA
$266M
| $1.01M | 0.01% |
64,469
-3,724
| -5% | -$58.5K |
|
|
GRTS
356
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $1.01M | 0.01% |
+78,678
| New | +$1.01M |
|
357
Scholar Rock
SRRK
$3.04B
| $1.01M | 0.01% |
40,623
-1,606
| -4% | -$39.9K |
|
358
ALX Oncology
ALXO
$58.4M
| $1.01M | 0.01% |
46,872
-2,576
| -5% | -$55.3K |
|
359
Gossamer Bio
GOSS
$630M
| $1M | 0.01% |
88,487
-4,649
| -5% | -$52.6K |
|
360
Trustmark
TRMK
$2.41B
| $1M | 0.01% |
30,835
-3,648
| -11% | -$118K |
|
|
KDNY
361
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $999K | 0.01% |
61,221
+6,318
| +12% | +$103K |
|
362
Fulton Financial
FULT
$3.5B
| $980K | 0.01% |
57,662
-5,012
| -8% | -$85.2K |
|
|
KLRS
363
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.5M
| $975K | 0.01% |
3,278
-192
| -6% | -$57.1K |
|
|
AGEN
364
Agenus
AGEN
$162M
| $957K | 0.01% |
+15,144
| New | +$957K |
|
365
Kezar Life Sciences
KZR
$29.4M
| $951K | 0.01% |
5,688
-219
| -4% | -$36.6K |
|
366
AngloGold Ashanti
AU
$31.3B
| $940K | 0.01% |
44,810
-8,813
| -16% | -$185K |
|
367
Gold Fields
GFI
$32B
| $940K | 0.01% |
85,541
-12,209
| -12% | -$134K |
|
368
Meta Platforms (Facebook)
META
$1.92T
| $938K | 0.01% |
2,788
-5,879
| -68% | -$1.98M |
|
|
UNIT
369
Uniti Group
UNIT
$1.76B
| $937K | 0.01% |
+66,849
| New | +$937K |
|
370
Old Dominion Freight Line
ODFL
$31.2B
| $932K | 0.01% |
5,200
+252
| +5% | +$45.2K |
|
|
IMGO
371
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $920K | 0.01% |
+38,802
| New | +$920K |
|
372
Qualcomm
QCOM
$171B
| $911K | 0.01% |
4,980
+2,405
| +93% | +$440K |
|
|
VXRT
373
DELISTED
Vaxart
VXRT
| $909K | 0.01% |
+144,972
| New | +$909K |
|
374
Norfolk Southern
NSC
$61.3B
| $907K | 0.01% |
3,046
+395
| +15% | +$118K |
|
375
Simon Property Group
SPG
$58.6B
| $906K | 0.01% |
+5,668
| New | +$906K |
|